Sign in
4/A

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0000899243-18-000546

Chief Executive Officer gave up 25,487 shares (to pay taxes)

  • Chief Executive Officer acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

WELCH WILLIAM J · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2018-01-02 Exercise or conversion : show line 1 in the form +50,000 800,142 D
2018-01-02 Shares withheld for taxes : show line 2 in the form −25,487 774,655 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-01-02 Exercise or conversion : show line 3 in the form Restricted Stock Units −50,000 280,000 D
Loading xslF345X03/doc4a.xml…